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INTRODUCTION 
  It is estimated that 9.3% of the American adult population, about 19 million 
people, are living with type 2 diabetes (1).  Of those with diabetes, it is estimated that 
6.5% are diagnosed and 2.8% are undiagnosed (1).  Furthermore, the prevalence and 
incidence of type 2 diabetes has been increasing every year (1).  Research has shown that 
type 2 diabetes is a risk factor for periodontal disease (2-7).  Furthermore, the incidence 
of periodontal disease has likewise shown a strong relationship between decreased 
control over the diabetic condition (8-10).   Since it is critical to achieve optimal 
glycemic control to prevent periodontal disease, the question is whether mindful-
meditation along with diabetes education vs. standard diabetes education alone, can help 
improve glycemic control.  If mindful-meditation along with diabetes education proves to 
be a more effective way of controlling the diabetic state, then it will offer more effective 
prevention for the incidence and severity of periodontal disease. 
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LITERATURE REVIEW 
Evidence suggests there is a bidirectional relationship between periodontal 
disease and type 2 diabetes.   
Type 2 diabetes and periodontal disease.  An assessment of current research 
shows that type 2 diabetes is a risk factor for periodontal disease.  Long-term, poor 
glycemic control, associated with type 2 diabetes, has been associated with the
 
incidence 
and progression of diabetes-related complications,
 
including gingivitis, periodontitis and 
alveolar bone loss (2-3).  Furthermore, it has been shown that people with poorly-
controlled diabetes have a higher prevalence of severe periodontitis (4). An overall 
assessment of the available data shows that diabetes is a risk factor for gingivitis and 
periodontitis (7).  
Diabetes is a complex disease characterized by a plethora of co-morbidities that 
may affect the overall state of periodontitis; however, research has determined a few 
mechanisms by which diabetes is believed to primarily be able to increase the prevalence 
and severity of periodontitis.  Among the studied mechanisms that increase periodontal 
disease are vascular changes/abnormalities (11-12), lipid metabolism imbalances (13-15), 
altered collagen metabolism (16-19), and neutrophil dysfunction (20-21). 
Vascular changes / abnormalities.  People with diabetes have commonly been 
known to have many vascular related co-morbidities, which has naturally led researchers 
to seek a determinable underlying mechanism.  Hyperglycemia is a common occurrence 
for people with diabetes and it is believed that hyperglycemia is among the forerunners 
for creating vascular dysfunction/abnormalities (11).  Hyperglycemia, or elevated blood 
glucose, exposes more glucose molecules which in turn are susceptible to binding with 
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amino groups of other molecules forming a glycosylation of proteins and lipoproteins 
(11).  When these molecules are glycosylated, they create a group of heterogeneous 
molecules known as advanced glycation end-products (AGE) (11).  Cell membrane 
proteins have been shown to bind AGEs, these cell membrane proteins are found in the 
oral cavity and include cells such as endothelial cells, smooth muscle cells, lymphocytes, 
and monocytes (11).  Binding of AGEs to endothelial cells has been shown to cause 
endothelial activation, a process which causes release of interleukin and tissue necrosis 
factor (11).  This efflux in turn creates increased leukocyte emigration as well as vascular 
permeability, two factors thought to influence development of periodontal disease (11).  
Although AGE formation has been linked to a host of other vascular related problems 
such as retinopathy, atherosclerosis, and renal failure (12), AGE related leukocyte 
emigration and increased vascular permeability are believed to be precursors to 
periodontal disease (11).   
Lipid metabolism imbalances. Type 2 diabetes has also been associated with 
hyperlipidemia, a condition hallmarked by excess blood lipids.  Hyperlipidemia has led 
researchers to question whether it is responsible for the underlying mechanisms that 
cause periodontal disease.  Some studies have found that infections can induce general 
disequilibrium or increase changes in cytokines and hormones which in turn alter lipid 
metabolism. (13).  Altered lipid metabolism leads to the development of hyperlipidemia.  
People with diabetes, who are subjected to hyperlipidemia, are especially affected by this 
disruption in fatty acid metabolism (13).  It has been shown that as diabetic control 
diminishes, increases in serum triglycerides ensue (14).  When neutrophils, infection 
fighting cells, in the oral cavity are exposed to increased serum triglycerides they are 
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believed to increase the production of pro-inflammatory cytokines, namely Interleukin-1 
beta (IL-1 ß) and Tumor Necrosis Factor-alpha (TNF-α)  (14).  These cytokines normally 
offer protection against infection; however, their disequilibrium is believed to be 
responsible for a diminished reparative response in the oral cavity tissue (15).  Therefore, 
a reduction in reparative function in the oral tissue leads to the increase and prevalence of 
periodontal disease in people with hyperlipidemia.  
Altered collagen synthesis.  As mechanistic evidence is suggested as to how 
diabetes leads to periodontal disease, researchers have begun to focus on the host 
response to these altering states.  Alteration in collagen production, maturation, and 
turnover are common in diabetes.  Because collagen is among the major structural 
proteins of the periodontum, these changes can contribute to impaired wound healing and 
increased severity of periodontal disease.  Research has found that decreased amounts of 
collagen and glycosaminoglycans are produced in high-glucose environments, such as 
hyperglycemia (16).  Both collagen and glycosaminoglycans are essential components of 
connective tissue and their decreased production in elevated glucose environments has 
been effectively reversed with insulin treatment in non-human models (17).  Not only do 
people with diabetes have decreased collagen production, but also their newly 
synthesized collagen molecules are more susceptible to degradation (18).  It has been 
found that an elevated level of matrix metalloproteinases (MMPs) accumulate in the 
diabetic state and these MMPs are capable of degrading newly synthesized collagen, 
damaging connective tissue (18).  To further the complications with collagen synthesis, 
AGEs alter existing collagen, making it highly crosslinked and very stable (19).  The 
connective tissue in people with diabetes produces less collagen (16), the collagen is 
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more susceptible to degradation (18), and the existing collagen can become crosslinked 
(19)  leading to the build-up of AGE-modified, stable complexes.  Therefore, the 
mechanistic alteration of collagen synthesis may lead to periodontal disease and 
decreased wound healing. 
Neutrophil dysfunction.  Neutrophils, a subcategory of leukocytic cells that aid 
infection fighting in the body, are responsible for aiding in mechanisms such as 
chemotaxis and phagocytosis (20).  Chemotaxis is the body’s cellular response to a 
stimulus, which often includes moving phagocytic cells into the proximity of infectious 
agents (20).  Once cells are in proximity of infectious agents, phagocytosis allows 
cellular uptake and destruction of these foreign infection particles (20).  Because these 
mechanisms aid in fighting infection, it is highly important for functioning neutrophils to 
protect the oral cavity and aid in the prevention of periodontal disease.  Previous research 
has shown that people with diabetes are likely to have decreased neutrophilic or 
polymorphonuclear (PMN) leukocytic functions such as phagocytosis and chemotaxis 
(21).  Therefore, it is no surprise that correlation has been found between decreased PMN 
leukocytic function and increased severity of periodontal disease (21).  Identification of 
the PMN dysfunction mechanism has led researchers to believe that possibly 
hyperglycemia, an increased level of blood glucose, is to blame (21).  Defects in 
neutrophilic function possibly due to hyperglycemia, therefore is believed to make people 
with diabetes also more likely to be susceptible to increases in the incidence and 
prevalence of periodontal disease. 
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Periodontal disease:  Decreased control of the diabetic state, averse effects. 
 
The correlation between diabetes and periodontal disease appears to be bidirectional.  
Researchers have been investigating the possibility that not only does diabetes lead to the 
incidence and prevalence of periodontal disease, but also that periodontal disease leads to 
decreased glycemic control. Decreased glycemic control can lead to hyperglycemia, 
hyperlipidemia, or dyslipidemia; these co-morbidities of diabetes have been pinpointed as 
possible mechanistic pre-cursors for periodontal disease.  Therefore, people with 
periodontal disease appear to be predispositioned for diabetes. 
Research supports that periodontal
 
infections contribute to complications with glycemic 
control (8) and some have shown that treating chronic periodontal infections is essential
 
for managing diabetes (22). 
 Infection induced glycemic control loss.  Periodontal disease is often associated 
with infection, which is considered a possible link to deterioration in glycemic control.  
Bacterial and viral infection has been linked with a host of systemic effects, including 
increased insulin resistance (23). Evidence suggests that periodontitis-induced bacteremia 
will
 
cause elevations in serum pro-inflammatory cytokines, leading
 
to hyperlipidemia, 
and ultimately causing an insulin-resistance
 
syndrome and contributing to destruction of 
pancreatic beta
 
cells (10). Insulin resistance leads to a loss of glucose uptake and 
therefore leads to a hyperglycemic state that can last for weeks after an infection (24).  
Hyperglycemia, elevated blood glucose, causes pancreatic B-cells to become over 
stimulated and eventually leads to their dysfunction (1).  B-cell dysfunction diminishes 
cellular glucose uptake and causes loss of glycemic control (1). 
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 Periodontal disease leads to diabetic complications.  Although much more 
information is focused on how diabetes leads to periodontal disease, some studies have 
focused on the converse relationship.  A 2-year longitudinal study demonstrated a sixfold 
increased risk of decreased glycemic control over time for people with diabetes and 
periodontal disease, when compared to people with diabetes without periodontal disease 
(25).  Other diabetic complications may be present in people with severe periodontitis.  
One longitudinal case study found that 81% of people with diabetes and severe 
periodontitis experienced the onset of at least one major vascular (cardiovascular, 
cerebrovascular, or peripheral vascular) event compared to only 21% of people with 
diabetes but without periodontal disease (26).  Another longitudinal study examined 
overall mortality and vascular related disease in over 600 people with diabetes (27).  
Diabetic nephropathy was 8.5 times higher in the group with severe periodontitis and the 
death rate from ischemic heart disease was also 2.3 times higher than the group without 
severe peritonitis (27).  The cardio-renal disease in the severe periodontitis group was 
likewise 3.5 times higher than in people with diabetes but without severe periodontitis 
(27). Since a possible link between periodontal disease leading to loss of glycemic 
control and other diabetic related complications has been under investigation, research 
has been initiated to examine how treating periodontitis might effect glycemic control. 
Effect of periodontal disease treatment on glycemic control.  Conflicting data 
make a definitive correlation between treatment of periodontal disease and loss of 
glycemic control skeptical at this point.  Some studies have found significant correlation 
between periodontitis treatment and glycemic control.  For example, a combination of 
scaling and root planing, in conjunction with doxycycline therapy, has been associated 
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with an improvement in periodontal status which was accompanied by significant 
improvement
 
in glycemic control, as measured by HbA1c levels (28-30).  However, a 
recent study found that when people with type 2 diabetes were treated as described 
above, and did have significant periodontal improvement, there was no significant 
improvement in HbA1c (31) .  Variation among studies, subjects studied, and results 
obtained have therefore created a need for more research to determine whether treating 
periodontal disease improves diabetes outcomes. 
Stress and diabetes.  Stress, whether physical or mental, causes the body to 
believe it’s under “attack”.  High stress levels in turn trigger the fight-or-flight response, 
which causes many hormones to be released, which are capable of priming the body (1).  
Hormones allow the body to prepare itself for stressful events by releasing stored energy, 
making glucose available for cells so that intense levels of activity are capable (1).  A life 
with high-stress levels can be a major complication for people with diabetes because 
glucose uptake into cells is compromised and a hyperglycemic state is maintained.  
Therefore, stress-reduction can lead to a decrease in hyperglycemia because stores are not 
as abundantly released into the blood.  Controlling the blood glucose level is key to 
controlling the diabetes and therefore may also be key to preventing periodontal disease 
in people with diabetes. 
 Mindfulness-based stress reduction.  A new approach for self-regulatory stress 
reduction known as Mindfulness-Based Stress Reduction (MBSR) is being employed by 
some in an attempt to reduce stress.   MBSR is a meditation technique that promotes 
relaxation through the nonjudgmental awareness of moment-to-moment sensations, 
experiences, and reactions.  Becoming mindful allows participants to become aware of 
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decisions they are making and cues that are felt in the body. This technique is possibly an 
effective way to reduce stress.  For example, one version of MBSR was found to 
significantly reduce the stress levels of medical students when used over a 10-week 
period (32).  Previously, people using MBSR have effectively reduced their stress levels, 
and therefore MBSR may likewise be an effective way for people with diabetes to reduce 
stress and thereby better glycemic control.   
METHODS 
Hypothesis: Similar test groups were set up and participants were randomized to 
one of two educational groups: (1) the Mindfulness Based-Eating Awareness Therapy 
group; or (2) a standard nutrition education group.  There will be a greater improvement 
in glycemic control (as measured by HbA1C) in adults with T2DM for the MB-EAT 
group compared to standard nutrition intervention group.   
Inclusion Criteria:  Those eligible for the study were men and women aged 35-
65 years who have been diagnosed with type 2 diabetes for at least 1 year, who did not 
require insulin treatment.  To be included, participants also had a Body Mass Index 
greater than 27.0 and HbA1c levels ≥ 7.0%.  Participants were willing to not engage in 
any other formal weight loss programs; furthermore participants on medication that could 
effect outcome variables maintained a stable dose throughout the duration of the study. 
Exclusion Criteria:  The exclusion criteria for the study were as follows: (1) 
persons with prescribed insulin therapy, (2) persons with co-morbid psychiatric 
conditions (i.e., drug abuse, suicidal ideation, psychosis) that would complicate group 
participation, (3) concurrent participation in another weight loss program during the 
course of the study, (4) unstable medical conditions or underlying weight problems 
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(thyroid disorder), (5) pregnancy or breast feeding, and (6) unwillingness to be 
randomized to differing treatment groups. 
Recruitment:  The OSU Primary Care Practice-Based Research Network, a 
member of the Agency for Health Research and Quality PBRN registry, was utilized to 
recruit subjects to this study.  The OSU-PCPBRN consists of 19 clinical primary sites 
including general internal medicine, sports medicine, family medicine, and occupational 
medicine.  OSU-PCPBRN provides care to over 6,000 patients with diabetes and is 
located throughout Franklin County, Ohio which serves a diverse population.  The 
primary site of the study is the OSU Rardin Family Practice Center.  The Rardin Center 
uses the same medical record systems and abides by the same protocols as larger practice 
networks.  The Rardin Center has nearly 49,000 patient visits a year, 8% of which are for 
diabetes-related treatment.  The Rardin Center serves nearly 900 patients with diabetes, 
which are made up of a diverse population of overweight and obese people, some who 
are in poor glycemic control and could benefit from additional intervention education.   
The OSU-PCPBRN includes a registry with over 6,000 patients with diabetes, 95% of 
which have type 2.  Those patients 35-65 years, diagnosed with type 2 diabetes for 
greater than 1 year, and having a BMI greater than 27.0 and an HbA1c greater than 7.0% 
received a letter regarding the proposed study.  All interested patients who contact the 
investigators were first screened by telephone, and then by BMI, and HbA1c values.  
Baseline data was collected and participants were randomized into one of two treatment 
groups.   
Randomization:  Participants were randomized into one of two treatment groups 
using block randomization. The block randomization was done within race to provide 
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balanced samples in the differing treatment groups.  According to enrollment, 
participants were grouped into 7 blocks and each block was split randomly into either 
group assignment. A non-study person determined which of the groups was assigned as 
treatment 1 and which was assigned as treatment 2 with the flip of a coin.   
  Intervention 1: Mindfulness Based-Eating Awareness Therapy (MB-EAT) is a 
multifaceted intervention approach that incorporates meditation intervention, along with 
mindful eating, body awareness, and incorporation of physical activity into a small group 
setting over a 10-week period.  Cultivation of “inner wisdom” which relates to mindfully 
being aware of what one is eating, as well as “outer wisdom” which is knowledge of food 
content and diabetes related needs, are the main goals of the intervention.  Participants 
were taught standard nutrition guidelines and also how to practice noticing hunger and 
satiety cues in an effort to thwart overeating.  Many forms of meditation were used, one 
of which is general mindfulness mediation.  This was used to train participants to simply 
notice without judgment the sensations of their physical body, as well as thoughts and 
emotions.  A second type of meditation was guided eating meditation.  The goal of this 
meditation was to teach participants to notice their own experiences, including behavior 
and emotional sensation, while they are consuming certain food items.  Other guided 
meditation such as forgiveness meditation, wisdom meditation, and emotion meditation 
were employed by the MB-EAT intervention group.  In addition to meditation training, 
participants received instruction in standard nutritional education.  Therefore, MB-EAT 
participants receive an intervention consisting of diabetes and nutrition education 
supplemented by mindful meditation practice in an effort to enhance the effects of 
controlling their diabetes. 
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Intervention 2:  The second group consisted of a similar program of 10-weeks of 
intervention but without training in mindful meditation, called the Smart Choices 
intervention.  This standard nutrition group was held under similar circumstances 
including group settings, with the same nutrition content.  The context of the standard 
nutrition group addressed key aspects of nutrition and physical activity as established by 
the American Diabetes Association (33).  The main areas of focus were relation between 
diet and glycemic control, portion control, type of carbohydrate, type and amount of fat, 
cholesterol, dining out guidelines, sample menus, healthy recipes, and physical activity.  
The education offered was appropriate for weight control and glycemic control for people 
with diabetes.  
Outcomes: Hemoglobin, a major component of oxygen transport in the blood was 
useful for measuring the effects of the intervention (34).  Hemoglobin is present in the 
blood along with glucose (34).  Over time, glucose slowly binds to the circulating 
hemoglobin which allows for statistical analysis to give an overview of the average blood 
glucose levels over about the past 2-3 months (34).  The glycated hemoglobin, HbA1c, 
was used to give a broad picture of where a person’s blood glucose level was over an 
extended period of time.  HbA1c levels of participants were recorded before and after the 
10-week intervention sessions.  Comparing the two differing groups change in HbA1c 
levels allowed for a conclusion to be drawn, whether a mindfulness-based intervention 
along with nutrition education was a better intervention for controlling diabetes than the 
standard nutrition intervention.  The intervention that achieved the biggest drop in HbA1C 
is likely a better intervention to reduce the likelihood of periodontal disease in people 
with diabetes. 
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Statistical Analysis:  Anthropometric and demographic data collected throughout 
the study were analyzed using SAS JMP (version 8.0, 2008, SAS Institute, Cary, NC).  
Fisher’s exact test or two-sample t-test were utilized to determine if any differences 
existed between the groups at baseline.  The residuals of the data were examined and 
were not normally distributed for fasting glucose and HbA1C. Likewise, the BMI and 
weight data for men were also not normally distributed.  Upon using analysis of 
covariance (ANCOVA), similar statistical results were noted while including all subjects 
and also while excluding outliers.  Since exclusion of outliers to normalize the 
distribution did not affect the statistical significance of the residuals, all subjects’ data 
were included.  ANCOVA was utilized for evaluation of both between- and within-group 
differences.  P values < 0.05 are considered statistically significant. 
 
RESULTS 
After randomization among those enrolled in the intervention, there were 18 
participants randomized to the MB-EAT group and 16 participants randomized to the 
Smart Choices group.  A demographic analysis between the MB-EAT group and the 
Smart Choices group is presented in Table 1.1.  There were no statistically significant 
differences in outcomes between the two groups after randomization.  At baseline, both 
MB-EAT and Smart Choices groups were similar in weight, waist circumference, BMI, 
HbA1C, and fasting glucose values (all P > 0.05) (see Table 1.2).  There was no 
significant difference between groups in the change in HbA1c.  At the conclusion of the 
10 week intervention, the Smart Choices group had significant losses within-group in 
weight, waist circumference, BMI, and HbA1C for both men and women. The MB-EAT 
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group had a significant decrease in HbA1C within-group, but did not have significant 
changes in weight, waist circumference, or BMI.  There was no significant change for 
either group in fasting plasma glucose. 
Variable MB-EAT (n=18) 
Smart Choices 
(n=16) P value
a
 
             (%)              
Female 61.1 56.2 1.00 
White 83.3 81.2 1.00 
Hispanic or Latino 5.6 6.2 1.00 
Married 61.1 68.8 0.73 
Bachelor's degree or higher 38.9 50.0 0.73 
Employed full-time 83.3 75.0 0.68 
Income ≥ $60,000 44.4 61.5 0.47 
Previous diabetes education 70.6 87.5 0.15 
Self monitoring blood glucose 70.6 68.8 1.00 
Oral Medication usage 94.4 87.5 0.59 
Health Insurance 94.4 81.2 0.32 
 Mean ± SE Mean ± SE  
Age (yrs) 54.8 ± 7.56 53.7 ± 6.41 0.64 
Years diagnosed with diabetes 7.3 ± 4.41 5.4 ± 3.19 0.14 
 
a Using Fisher’s exact test, or two-sample t-test for between group comparisons 
 
Table 1.1.  Demographic characteristics of adults with type 2 diabetes at baseline 
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DISCUSSION 
About 9.3% of the American adult population, around 19 million people, are 
living with diabetes (1).  With such a large percentage of the population affected, and the 
number of new cases continually growing, it is now more critical than ever for health 
professionals to develop effective interventions to combat this disease.  Since diabetes is 
a risk factor for developing periodontal disease (2-7), dental professionals in particular 
may benefit from understanding the latest and most effective diabetes interventions.  
Therefore, determining whether diabetes interventions focused on mindfulness based 
meditation offer a more effective intervention than standard diabetes education is needed.   
Better diabetes management is achieved with optimal glycemic control.  To obtain 
an estimate of the average blood glucose over time, health professionals determine the 
percentage of glycosylated hemoglobin, HbA1C, present in the blood.  Higher levels of 
blood glucose mean more hemoglobin is glycosylated (34). Higher percentages for 
HbA1C ultimately mean a higher risk for co-morbidities such as periodontal disease (34).  
Therefore, significant reductions in HbA1C, reduce the risk for periodontal disease.   
The Smart Choices group had a significant within-group change in HbA1C 
following the 10 week intervention, with a mean (±SE) decrease of -0.71 ± 0.30 % (P = 
0.02).  The MB-Eat group had a near identical within-group change over the 10 weeks 
with a mean decrease in HbA1C of -0.67 ± 0.28 % (P = 0.02).  Although both groups 
significantly lowered the HbA1C levels within group, no significant difference in the 
change in HbA1C was observed between the two groups.  Determining the more effective 
intervention for improving glycemic control was indeterminable since each group 
experienced similar decreases in HbA1C and no significant difference between groups 
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was observed (P = 0.91).  Therefore, both treatments are effective, but the hypothesis that 
the MB-EAT group would experience a greater improvement in glycemic control was not 
supported by the findings.    
A significant difference in the change in weight, waist circumference, and BMI 
between women in the Smart Choices group compared to women in the MB-EAT group 
were noted.  Women in the Smart Choices group lost more weight.  The Smart Choices 
group also noted significant within-group losses for men in weight, waist circumference, 
and BMI.  The MB-EAT group did not experience any significant change in weight, 
waist circumference, or BMI such as the Smart Choices group.  Therefore, the Smart 
Choices (SC) intervention may be more effective in reducing the risk for chronic weight-
related diseases. 
This study had several limitations that could have an effect on the results 
obtained.  The majority of participants in this study were white (83.3% MB-EAT vs. 
81.2% SC), women (61.6% MB-EAT vs. 56.2% SC), with previous diabetes education 
(70.6% MB-EAT vs. 86.5% SC).  The study was implemented among those with poor 
glycemic control and at greater risk for periodontal disease.  The impact of the 
interventions among samples with differing cultural, educational, and ethnic backgrounds 
will require further research.   
 Future research also should assess the condition of periodontal disease among 
participants.  Since periodontal disease is a common co-morbidity of diabetes (2-7), 
future research should consider how the mechanisms that lead from diabetes to 
periodontal disease are affected, if at all, by both the Smart Choices and MB-EAT 
interventions.  Monitoring vascular changes, lipid metabolism, collagen synthesis, and 
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neutrophil function while undergoing intervention could give dental professionals 
evidence for the effectiveness of diabetes interventions in preventing periodontal disease.    
Optimal glycemic control is necessary for people with type 2 diabetes to reduce 
the risk of developing co-morbidities.  High glycemic levels can be a result of high stress 
levels, and utilizing mindfulness may be particularly useful for people with diabetes to 
reduce their risk for co-morbidities related to diabetes.  The mindfulness intervention was 
equally effective as the standard diabetes intervention at lowering HbA1C .  It seems 
people with diabetes may have several options for combating this disease. Both 
approaches, MB-EAT and Smart Choices, effectively lowered the within-group HbA1C 
levels and therefore offer people with diabetes options for achieving optimal glycemic 
control.  In the future, research is needed to evaluate the effect of both treatments on the 
occurrence and severity of periodontal disease.   
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